IDenta Corporation News
29 articles
IDenta Corp Reports Remarkable Results in 2024 Annual Report
IDenta Corp., a leader in the development of field detection and home diagnostic testing kits, reported significant growth and increased profitability in 2024. The companys annual report highlights a substantial increase in revenues and net profit, driven by strong customer satisfaction and operational efficiency improvements. The strategic expansion into new markets through new distributors has broadened IDenta Corp.s market presence, contributing to impressive revenue growth. The companys commitment to operational excellence and customer satisfaction has set a strong foundation for continued success. Key financial highlights include a revenue increase to $1,455,488 and a net profit rise to $258,343 in 2024.
CustomersPartners
IDenta Corp Reports Third Quarter 2024 Results with 100% Increase in Sales
IDenta Corp., a leader in field detection and home diagnostic testing kits, announced a significant achievement for the third quarter of 2024, reporting a 100% increase in sales compared to the same period last year. The company has expanded its market share and introduced groundbreaking innovations, resulting in improved gross margins and operating efficiencies. Revenues for the third quarter of 2024 were $366,870, doubling from $173,451 in the third quarter of 2023. Gross profit increased to $274,542, and net profit rose to $102,344, compared to a loss in the previous year. Cash and cash equivalents also increased significantly. The company remains confident in sustaining this momentum and delivering long-term value to shareholders and customers.
IDenta Corp Reports Second Quarter 2024 Results with Impressive Increase in Revenue and Profitability
IDenta Corp., a leader in the development of field detection and home diagnostic testing kits, reported a significant increase in sales and net profit for the second quarter of 2024. The companys revenues rose to $360,988, up from $188,494 in the same quarter of 2023. Gross profit also increased, reaching $258,326, while operating profit improved to $72,558. Net profit for the quarter was $79,901, a notable improvement from a loss of $76,334 in the previous year. The company attributes its success to wise resource management, new customer growth, and expanded operations in existing markets.
Customers
IDenta Corp Reports Second Quarter 2024 Results with Impressive Increase in Revenue and Profitability
IDenta Corp., a global leader in the development of Field Detection and Home Diagnostic Testing Kits, has reported an increase in sales and net profit in its Q2 2024 financial statement. Despite challenging global conditions, the company has managed to grow with new customers and expand operations in existing markets. Revenues for Q2 2024 were $360,988, compared to $188,494 in Q2 2023. Gross profit increased to $258,326 in Q2 2024, compared to $124,934 in Q2 2023. Net profit for Q2 2024 was $79,901, compared to a net loss of $76,334 in Q2 2023.
CustomersExpand
IDenta Corp - 2024 Shareholders' Meeting - Updating
IDenta Corp., a global leader in the development of field detection and home diagnostic testing kits for narcotics, explosives, and forensic products, is set to hold a shareholders meeting on July 4th, 2024. The meeting will discuss a change in the companys structure following an initial proposal approved by the board of directors and management. The meeting will be accessible both in-person at the companys offices in Jerusalem and via Zoom. IDenta Corp. is known for its innovative products that meet high standards of law enforcement and security agencies worldwide.
IDenta Corp - 2024 Shareholders' Meeting - Updating
IDenta Corp., a global leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives, and Unique Forensic Products, will hold a Shareholders meeting on July 4th, 2024. The meeting will discuss a change in the companys structure after approval of an initial proposal by the companys board of directors and management. The meeting will be held at the companys offices in Jerusalem and via Zoom link.
Management Changes
IDenta Corp - 2024 Shareholders' Meeting
IDenta Corp, a global leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets, is set to hold a shareholders meeting on July 1st, 2024. The meeting will be held via Zoom to allow for global participation. CEO Amichai Glattstein expressed excitement about the upcoming meeting.
Management Changes
IDenta Corp - 2024 Shareholders' Meeting
IDenta Corp., a global leader in the development and supply of field detection and home diagnostic testing kits for drugs, explosives, and unique forensic products, is set to hold a shareholders meeting on July 1st, 2024. The meeting will be conducted via Zoom, allowing global participation. The company, which serves both professional law enforcement and retail markets, is known for its products that meet high standards of law enforcement and security agencies worldwide. The announcement is seen as a positive step for the company, highlighting its commitment to transparency and engagement with its shareholders.
IDenta Corp Reports Blowout First Quarter 2024 Results with Strong Increased in all Categories
IDenta Corp., a global leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products, has reported a significant improvement in its 2024 first quarter financial statement. The companys revenues for the first quarter of 2024 were $428,346, compared to revenues of $231,623 in the first quarter of 2023. The gross profit also increased to $354,118 in the first quarter of 2024 compared to a gross profit of $179,482 in the first quarter of 2023. The company continues to distribute its products, expand its customer base and optimize its production.
CustomersExpand
IDenta Corp Reports 2023 Second Quarter Financial Results and Got a GSA Contract to Expand the Activities with USA Government
IDenta Corp, a global leader in the development of Field Detection and Home Diagnostic Testing Kits, has reported its Q2 2023 financial statement and announced a GSA contract with the US government. Despite a slowdown in sales, the company continues to improve its marketing and sales infrastructure, and is now an official supplier to the GSA platform. This will make the companys products accessible to government agencies in the US. However, revenues, gross profit, operating profit and net profit for Q2 2023 have all decreased compared to Q2 2022.
CustomersExpand
IDenta Corp Reports 2023 First Quarter Financial Results and Continues to Invest in Activities with US Government Customers and Retail Markets for Fentanyl Detection Solutions
IDenta Corp. reported its 2023 first quarter financial statement and continues to invest in expanding operations in the U.S. market. The company expects the demand for fentanyl detection methods to continue growing due to the ongoing opioid crisis. IDenta Corp. has added a variety of products to identify Fentanyl and derivatives, which are useful for law enforcement agencies, border control, and workplace drug testing. The company plans to expand its activities in the Fentanyl detection world. However, the companys revenues, gross profit, operating profit, net profit, and cash and cash equivalents have all decreased in the first quarter of 2023 compared to the first quarter of 2022. The financial decline is attributed to continuing investments in marketing and sales in the US market.
Expand
iDenta discusses company's efforts to combat the opioid epidemic with product line of testing
Amichai Glattstein, the CEO of iDenta, a leading detection and forensic science company, has joined Proactives Natalie Stoberman to discuss how the company is addressing the opioid epidemic with its science-based products. iDenta uses the latest technology to provide solutions to law enforcement, military, government agencies, and other organizations that face the demanding and constantly changing challenges of combating illicit drugs and terrorist threats worldwide.
Management Changes
IDenta Corp Reports Annual Financial 2022 Results and Shows Efficiency and a Sharp Increase in Annual Profit
IDenta Corp. reported its 2022 annual financial statements, showing a sharp increase in net profit due to the optimization of the production line, management of employees, and the sale of a new product line. The company invested in building infrastructure in the US market, expanding relationships with local distributors, and participating in trade shows. Despite a decrease in revenue, gross profit increased, and net profit saw a significant increase. Cash and cash equivalents also increased. IDenta Corp. is a global leader in the development and supply of Field Detection and Home Diagnostics Testing Kits for Drugs & Explosives and Unique Forensic Products.
Investment
IDenta Corp Reports 2022 Third Quarter Financial Results, Shows Profitability in All Parameters
IDenta Corp. reported an increase in gross profit, operating profit, and net profit in its 2022 third quarter financial statement compared to the same period last year. The company also mentioned progress and solidification of partnerships, participation in exhibitions, and infrastructure building in the US market. The CEO expressed pride in the accomplishments and confidence in the companys ability to drive excellence and create long-term value. Revenues for the third quarter of 2022 were $332,296, with a 31% increase in gross profit. Operating profit increased significantly, and net profit showed a significant increase despite a complex global period and high exchange rate changes. Cash and cash equivalents decreased to $324,475.
PartnersExpand
IDenta Corp Develops Test Kit to Identify Fentanyl in Cocaine and Crack, Available for Purchase Online
IDenta Corp. has developed a Fentanyl detection kit to identify the presence of Fentanyl in drugs. The kit is sold under the companys Consumer Brand Touch&Know and is available for purchase on the companys website and Amazon. The test kit is inexpensive and provides results within minutes. The article emphasizes the importance of testing drugs for Fentanyl, as it can be deadly and is often laced with other substances. IDenta Corp. is a global leader in the development and supply of field detection and home diagnostics testing kits for drugs and explosives. The companys products are used by law enforcement and security agencies worldwide.
Customers
IDenta Corp Reports 2022 Second Quarter Financial Results, Shows Profitability and a Significant Expansion in the US Market
IDenta Corp. reported an increase in sales and profit in its 2022 second quarter financial statement. The company showed a return to growth and expanded its marketing infrastructure in the US market. Revenues for the second quarter of 2022 were $378,982, and net profit was $7,488. Cash and cash equivalents increased to $303,853. The company focuses on the development and supply of Field Detection and Home Diagnostics Testing Kits for Drugs & Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets.
Customers
IDenta Corp to Equip Cargo Detection for UPS, FedEx and DHL Couriers by Federal Police in Brazil
IDenta Corp. will supply detection field kits to the Federal Police in Brazil to check packages for UPS, FedEx, and DHL couriers. The companys products continue to reach customers in different fields and countries, contributing to potential growth. IDenta Corp. is a global leader in the development and supply of field detection and home diagnostics testing kits for drugs and explosives, as well as unique forensic products. The companys technology is simple to use, safe, reliable, and accessible to everyone. The article does not mention any specific partners, customers, valuation amount, acquisition amount, investment amount, layoffs, or date of the event.
Customers
IDenta Corp Receives $525,000 Order from The French Ministry of The Interior Assuring the Best First Quarter Ever
IDenta Corp. has received an order worth $525,000 from French Government Authorities, demonstrating their ongoing confidence in IDenta technology. The CEO expects this order to mark the beginning of the companys best year yet, as the demand for their technology has risen due to the COVID pandemic. IDenta Corp. is a global leader in the development and supply of Field Detection and Home Diagnostics Testing Kits for Drugs & Explosives and Unique Forensic Products. The companys products are used in the Homeland Security and Consumer Markets and are highly regarded by law enforcement and security agencies worldwide.
Customers
IDenta Corp to Equip all ELAL Airlines Security Checkpoints Worldwide
IDenta Corp. has entered into a supply agreement with ELAL Airlines for the use of IDentas illicit substance testing kits at all ELAL security inspection points globally. The agreement involves adapting IDentas field testing product lines to meet the requirements of ELALs security teams. The technology allows for safe, fast, reliable, and cost-efficient on-site diagnosis of substances without direct physical contact or contamination. IDenta Corp. expects that other airline carriers will also incorporate their on-site testing kits as air travel resumes.
Partners
IDenta Corp Launches the TANKER Explosives Trace Detector for Airlines and Airports
IDenta Corp, a global leader in the development of Drug, Drug Precursor and Explosive Detection field kits, has announced the launch of the TANKER, a new technology for continuous detection of explosive residue on people, objects, and surfaces. The TANKER is designed for multiple examinations with up to 600 tests per kit and delivers unmatched sensitivity for a broad range of explosives. The company expects the new product to attract new customers at airports and airlines worldwide.
CustomersExpand
IDenta Corp Reports 2019 Third Quarter Financial Results Surpassing all of 2018 Sales
IDenta Corp, a global leader in the development of Detection Kits for Drugs and Explosives, has reported its 2019 third quarter financial statement. The companys revenues for the first three quarters of 2019 were $918,997, compared to $654,305 for the same period in 2018. CEO Amichai Glattstein attributed the improved results to product expansion and penetration into new markets. The company is tailoring targeted solutions to new customers based on its broad product platform.
CustomersExpand
IDenta Corp Signs $2.5 Million Contract for Drug & Explosive Field Detections Kits
IDenta Corp. has announced a contract with an important Asian country to supply its unique drug and explosive detection products. The contract is valued at $2.5 million over five years and represents the largest contract in the companys history. This contract is seen as a tremendous achievement and a potential for IDentas growth in this and other countries. The companys customers are satisfied with the products, which have shown superiority in the field and in laboratory tests. IDenta Corp. is a worldwide leader in the development of field Drug & Explosive kits and unique forensic products for homeland security and the consumer market.
Customers
IDenta Corp Reports First Quarter 2019 Results With Increase of 31% in Sales BioSpace
IDenta Corp. has reported a sales increase of over thirty percent in the first quarter of 2019 compared to the same period last year. The CEO attributes this strong performance to the foundational work done in 2018 to position the company for sustainable and profitable growth. IDenta Corp. is focused on developing field drug and explosive detection kits and forensic products. They have been recognized as a worldwide leader in this industry since 2002. The company plans to continue its growth trajectory and launch new and unique products in the near and far future.
Customers
IDenta Corp - Sales Multiply, Company Becomes Profitable in 2018
IDenta Corp. has published its annual financial statement for 2018, showing a leap in sales and a move to profitability. The company experienced major changes and challenges, including new officers and products. IDenta also entered into several new partnerships, contributing to its profitability. The CEO expressed excitement about the potential for 2019 and the future, as the company aims to expand its sales potential, enter new markets, and contract with new customers. IDenta Corp. is a worldwide leader in the development of field drug and explosive detection kits and forensic products.
PartnersExpand
Chinese Market Started Using IDenta Corp's Technology
IDenta Corp. has successfully entered the Chinese market with its range of drug and explosive detection kits. The company has delivered an initial order worth $40,000 to local security forces for training and implementation. IDenta Corp. sees the Chinese market as having enormous potential for its technologies and solutions, and it plans to continue expanding its activities there. Since 2002, IDenta Corp. has been a global leader in developing on-site drug, drug precursor, and explosive detection kits. The companys products have consistently passed qualifications and testing procedures of law enforcement and security agencies worldwide.
Customers
$168 Million Worth of Cocaine was Discovered in Busan Port, Korea by IDenta Corp's Kit
IDenta Corp, a worldwide leader in the development of Drug, Drug Precursor and Explosive Detection kits, has announced the successful use of their kits in discovering $168 million worth of cocaine in Korea. This significant seizure demonstrates the added value of IDentas technology. The company continues to grow and expand in various markets, achieving important milestones and goals. IDenta Corp has been recognized since 2002 for their proprietary detection kits, which are highly reliable, top quality, and easy to use. The companys products are used by law enforcement and security agencies worldwide. IDenta Corp is committed to ongoing development and distribution of their revolutionary products.
CustomersExpand
IDenta Corp. gets U.S. patent approval for drugs and explosives detection device
Press Releases Archive - Digital Journal
IDenta Corporation Announces Reverse Share Split
IDenta Corp. has announced a reverse share split of its shares at a ratio of 1-for-4,000. The reverse share split became effective on June 20, 2017. The companys ordinary shares will continue to trade on the OTC Pink Sheet. The new stock symbol for a period of 20 business days will be IDTAD and will revert back to IDTA thereafter. The reverse share split will result in a decrease in the companys issued and outstanding ordinary shares to 4,024,958 shares post-split.
Public Trading
